The Bloomsbury building, which was developed by Oxford Properties and Pioneer Group, is already home to nine digital health and AI-driven research start-ups.
Developed by Oxford Properties and Pioneer Group, converted by CW Architects and delivered by contractor Wates, Victoria House in Bloomsbury Square has launched as a life sciences hub.
The London building offers a combination of lab-enabled, fully fitted and incubator laboratory space and serviced offices within technical and tailored infrastructure to support the lifecycle of life sciences companies as well as multinational pharmaceutical and biotechnology businesses, academic research institutions, government agencies, and venture capital firms.
“With the leasing momentum already achieved, we have begun to build a strong science and tech-based ecosystem at Victoria House, with occupiers attracted by the wide range of offers from incubator spaces for start-ups to larger offices for established companies, alongside excellent amenities – all in a historic setting within London’s Knowledge Quarter,” said James Boadle, European managing director of Oxford Properties.
Life sciences opportunities
Victoria House is the first location in London to combine incubator labs with fully serviced office space in a Grade II-listed building, specifically tailored for life sciences. The fourth floor is already home to nine digital health and AI-driven research start-ups, including Deep Mirror, Caerulus Genomics, Neurocentrx, M2M Bio, and Forcefield Therapeutics, as well as clinical-stage biotech AAVantgarde Bio.
Residents in the incubator labs on the seventh floor include four early-stage companies – Xterna, AAVantgarde Bio, Curecraft, and Emles Bioventures – spanning research in cancer therapies, therapeutic proteins and next-generation health tech.
The building is also home to the BioIndustry Association (BIA), which established its UK headquarters at Victoria House last year.
The opening of Victoria House builds on the life sciences opportunities within the capital. In April, the borough of Hammersmith & Fulham announced the formation of an innovation cluster – the Fulham Riverside Life Sciences Precinct – which will be developed with Imperial College NHS Healthcare Trust and Imperial College London. And after £52 million investment, Hale House was opened in the Harley Street Health District to be a hub for healthtech.
